Recombinant
RabMAb

Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (ab108980)

Publishing research using ab108980? Please let us know so that we can cite the reference in this datasheet.

ab108980 has been referenced in 5 publications.

  • Chou TF  et al. Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1a for Th17 suppression. Nat Commun 7:11904 (2016). WB ; Human . PubMed: 27312851
  • Zamudio-Cuevas Y  et al. Monosodium urate crystals induce oxidative stress in human synoviocytes. Arthritis Res Ther 18:117 (2016). PubMed: 27209322
  • Lalevée S  et al. miR455 is linked to hypoxia signaling and is deregulated in preeclampsia. Cell Death Dis 5:e1408 (2014). PubMed: 25188518
  • Van Welden S  et al. Differential expression of prolyl hydroxylase 1 in patients with ulcerative colitis versus patients with Crohn's disease/infectious colitis and healthy controls. J Inflamm (Lond) 10:36 (2013). WB, IHC-P ; Human . PubMed: 24257430
  • Taniguchi CM  et al. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nat Med 19:1325-30 (2013). PubMed: 24037093

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up